2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Relapsed T-Cell Lymphoma: new trials by email Literature Review of Relapsed T-Cell Lymphoma trials Research Report on Relapsed T-Cell Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies Fludarabine, Melphalan, Total Body Irradiation - Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia | Phase 2 | Completed | H. Lee Moffitt Cancer Center and Research Institute | 34 | 2019-12-06 | 2025-12-11 |
| UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep Fludarabine, Cyclophosphamide, MMF - Acute Leukemia, Acute Myeloid Leukemia | Phase 2 | Completed | Masonic Cancer Center, University of Minnesota | 15 | 2017-05-15 | 2025-07-04 |
Burkitt Lymphoma (2) · Dendritic Cell Sarcoma, Interdigitating (2) · Hodgkin Disease (2) · Leukemia, Lymphocytic, Chronic, B-Cell (2) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (2) · Leukemia, Myeloid, Acute (2) · Leukemia, Prolymphocytic (2) · Lymphoma, B-Cell, Marginal Zone (2) · Lymphoma, Follicular (2) · Lymphoma, Mantle-Cell (2) · Lymphoma, T-Cell (2) · Myelodysplastic Syndromes (2) · Myeloproliferative Disorders (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Bone Marrow Failure Disorders (1)
Bone Marrow Diseases (2) · Chronic Disease (2) · DNA Virus Infections (2) · Disease Attributes (2) · Epstein-Barr Virus Infections (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Herpesviridae Infections (2) · Histiocytic Disorders, Malignant (2) · Histiocytosis (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Infections (2) · Leukemia, B-Cell (2) · Leukemia, Lymphoid (2)
Whole-Body Irradiation (2) · fludarabine (2) · fludarabine phosphate (2) · Antilymphocyte Serum (1) · Cyclophosphamide (1) · Melphalan (1) · Mycophenolic Acid (1) · Sirolimus (1)
H. Lee Moffitt Cancer Center and Research Institute (1) · Masonic Cancer Center, University of Minnesota (1)
United States (2)